Precigen (PGEN) Interest & Investment Income (2012 - 2026)
Precigen (PGEN) posted quarterly Interest & Investment Income of $683000.0 for Q1 2026, down 25.6% year-over-year from $918000.0 in Q1 2025, and down 35.99% quarter-over-quarter from $1.1 million in Q4 2025.
Powered by 
Analysis
Precigen (PGEN) Interest & Investment Income (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Interest & Investment Income for 15 consecutive years, with $683000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income fell 25.6% year-over-year to $683000.0; the TTM figure through Mar 2026 stood at $3.0 million (up 72.45% YoY), while the FY2025 annual figure was $3.2 million, up 126.73% from the prior year.
- Interest & Investment Income fell to $683000.0 in Q1 2026 per PGEN's latest filing, from $1.1 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.1 million in Q4 2025 and bottomed at $2000.0 in Q4 2022.
- Historically, Interest & Investment Income has averaged $511000.0 across 5 years, with a median of $608000.0 in 2024.
- Annual changes were most pronounced in 2022 — Interest & Investment Income plunged 95.24% — and 2023, when it jumped 45950.0%.
- Precigen's Interest & Investment Income stood at $2000.0 in 2022, then surged by 45950.0% to $921000.0 in 2023, then sank by 77.42% to $208000.0 in 2024, then jumped by 412.98% to $1.1 million in 2025, then tumbled by 35.99% to $683000.0 in 2026.
- Business Quant data shows PGEN's Interest & Investment Income at $683000.0 in Q1 2026, $1.1 million in Q4 2025, and $534000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | 366,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 366,000.00 |
| Mar 31, 2026 | 683,000.00 |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 534,000.00 |
| Jun 30, 2025 | 696,000.00 |
| Mar 31, 2025 | 918,000.00 |
| Dec 31, 2024 | 208,000.00 |
| Sep 30, 2024 | 283,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Mar 31, 2024 | 608,000.00 |
| Dec 31, 2023 | 921,000.00 |
| Sep 30, 2023 | 856,000.00 |
| Jun 30, 2023 | 828,000.00 |
| Mar 31, 2023 | 633,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 56,000.00 |
| Jun 30, 2022 | 37,000.00 |
| Mar 31, 2022 | 38,000.00 |
| Dec 31, 2021 | 42,000.00 |
| Sep 30, 2021 | 48,000.00 |